These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30466680)

  • 1. Gastroenterology for the Internist.
    Dunbar KB
    Med Clin North Am; 2019 Jan; 103(1):xvii-xviii. PubMed ID: 30466680
    [No Abstract]   [Full Text] [Related]  

  • 2. [From reflux to irritable bowel syndrome: hot topics from gastroenterology].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Apr; 153(15):12-4. PubMed ID: 21667551
    [No Abstract]   [Full Text] [Related]  

  • 3. The reason for failure of on-demand PPI therapy in NERD patients.
    Savarino E; Zentilin P; Savarino V
    Neurogastroenterol Motil; 2011 Aug; 23(8):811. PubMed ID: 21762283
    [No Abstract]   [Full Text] [Related]  

  • 4. Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) - Study section "Digestive Diseases in Primary Care".
    Savarino V; Tosetti C; Benedetto E; Compare D; Nardone G
    Dig Liver Dis; 2018 Sep; 50(9):894-902. PubMed ID: 30093304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
    Funaki Y; Kaneko H; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese Experience for the American Journal of Gastroenterology.
    Miwa H
    Am J Gastroenterol; 2018 Oct; 113(10):1403-1404. PubMed ID: 30166632
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
    Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Causes of functional digestive disorders and therapeutic approach in primary care medicine].
    Coman AE; Popa E; Grigore C; Maidaniuc M; Petrovanu R
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):75-9. PubMed ID: 20509279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Therapies in Gastrointestinal Diseases.
    Fox RK; Muniraj T
    Med Clin North Am; 2016 Jul; 100(4):827-50. PubMed ID: 27235617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highlights in gastroenterology 2006].
    Bauerfeind P; Müllhaupt B; Schöfl R; Rösch T; Schwizer W; Wirth HP; Kullak-Ublick GA; Fried M
    Praxis (Bern 1994); 2006 Nov; 95(46):1793-804. PubMed ID: 17136827
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia.
    Friesen CA; Rosen JM; Schurman JV
    BMC Gastroenterol; 2016 Jul; 16(1):75. PubMed ID: 27457769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD.
    Kennedy M; Ford AC
    Aliment Pharmacol Ther; 2012 Jul; 36(2):207; author 207-8. PubMed ID: 22703466
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of clinical characteristics between non-erosive reflux disease and reflux esophagitis].
    Pan HY; Xiang XL; Lyu SZ; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):510-4. PubMed ID: 27373284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-oesophageal reflux disease and irritable bowel syndrome significantly associated with metabolic syndrome.
    Cholongitas E; Pipili C; Dasenaki M
    Scand J Gastroenterol; 2008; 43(11):1405-6. PubMed ID: 18752148
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor.
    López-Colombo A; Pacio-Quiterio MS; Jesús-Mejenes LY; Rodríguez-Aguilar JE; López-Guevara M; Montiel-Jarquín AJ; López-Alvarenga JC; Morales-Hernández ER; Ortiz-Juárez VR; Ávila-Jiménez L
    Rev Gastroenterol Mex; 2017; 82(2):106-114. PubMed ID: 28283313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.
    Howden CW; Vakil NB
    Gastroenterology; 2017 Mar; 152(4):e1-e4. PubMed ID: 28147223
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in Gastrointestinal Diseases in Japan.
    Shinomura Y
    Digestion; 2016; 93(1):5-6. PubMed ID: 26790101
    [No Abstract]   [Full Text] [Related]  

  • 20. Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations.
    Crespi M; Ghidotti I; Bodini G; Furnari M; Marabotto E; Giannini EG
    Dig Liver Dis; 2019 Jan; 51(1):173-174. PubMed ID: 30366811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.